Féminin Sacré - Pleine Lune
Food supplement declared in France, declaration No 2023-8-329
Féminin Sacré - Pleine Lune (Ælixir Ælchimique) is a food supplement declared in France. Status: withdrawal from the market announced for 30 November 2028. Main ingredients: Alchemilla vulgaris 335 mg per day, Achillea millefolium 206 mg per day, Vitex agnus-castus 129 mg per day, Rubus idaeus 60 mg per day, miel. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Ælixir Ælchimique
- Food business operator placing the product on the market
- VITURET Florent
- Status
- Withdrawal from the market announced for 30 November 2028
- Form
- Dropper
- Daily dose
- 90 gouttes soit 834mg d'extrait
- Directions for use
- 30 gouttes diluées dans un verre d'eau, 3 fois par jour pendant 3 semaines.
- Intended populations
- Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Taking anticoagulants, Taking antidepressants, Taking blood pressure medication, Taking medication, Taking thyroid medication, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Menstrual cycles, Mood
Declaration 272222, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Alchemilla vulgaris L. | Parties aériennes | Alcoolature | 335 mg |
| Achillea millefolium L. | Sommités fleuries | Alcoolature | 206 mg |
| Vitex agnus-castus L. | Fruit | Alcoolature | 129 mg |
| Rubus idaeus L. | Jeune pousse | Autre macérât | 60 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
| Eau de mer | not declared |
Other ingredients
Eau osmosée dynamisée, Alcool
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ce produit additionne les contre-indications de chacune des plantes qui le compose, il est donc contre-indiqué à la femme enceinte, allaitante, à l'enfant de moins de 12 ans, en cas d'antécédant de cancer du sein, à l'Homme et à toutes personnes sous traitement médicamenteux ou en cours de fécondation In-Vitro. Détail :L'Alchémille est contre-indiqué à la femme enceinte, allaitante et à l'enfant de moins de 12 ans (alcool) ;L'Achillée Millefeuille nécessite une surveillance médicale en cas de traitement anti-coagulant ;Le Gattilier est en plus contre-indiqué à l'Homme, aux personnes sous fécondations in-vitro et en cas de traitements médicamenteux par mesure de précaution.Le Framboisier n'ajoute pas de contre-indications supplémentaires.
Regulatory points
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawal from the market announced for 30 November 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitex agnus-castus L.
Read the warning, when it applies and the studies cited
CHASTE TREE - VITEX AGNUS-CASTUS
Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).
Sources cited by Health Canada (4)
- Bradley PR, editor. 2006. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
- OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.
Contraindications
Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).
Sources cited by Health Canada (9)
- Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dugoua JJ, Seely D, Pern D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex Agnus-Castus) during pregnancy and lactation. Can J. Clin Pharmacol 2008;15(1);e74-e79.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Vitex agnus-castus L., fructus. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 27 March 2018. [Accessed 2024 February 29] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vitex-agnus-castus-l-fructus-revision-1_en.pdf
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy in collaboration with Thieme.
- Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
- Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J. Pharmacopuncture 2022;25(2):106-113. PubMed
- WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
- OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Ælixir Ælchimique
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Féminin Sacré - Pleine Lune (Ælixir Ælchimique): composition and regulation”, https://compoatlas.com/en/supplements/products/272222-feminin-sacre-pleine-lune, updated 15 November 2026.